Immunomic Therapeutics
Latest round
- Series A
Last raised
- Mar 2010
Total raised
- $0.6M
Investors
- 4
About Immunomic Therapeutics
Immunomic Therapeutics, Inc.Immunomic Therapeutics, Inc. was founded in 2005 in Rockville, US, and specializes in developing immunotherapeutic vaccines. The company has undergone strategic pivots focusing on the therapeutic application of its UNITE® platform in oncology., Ltd.Immunomic Therapeutics, Inc. specializes in developing innovative vaccines through its proprietary UNITE® platform, which enhances immune responses to combat various cancers and allergies. Its primary products include ITI-1001, targeting cytomegalovirus (CMV)-associated antigens in newly diagnosed Glioblastoma Multiforme (GBM), and ITI-1771, aimed at treating CMV-driven cancers. Additional offerings are ITI-5000 for Triple Negative Breast Cancer, ITI-9001 for Japanese Red Cedar Allergy, ITI-8000 as a next-generation checkpoint inhibitor, and ITI-2000 for HPV+ tumors related to head and neck cancers.Immunomic Therapeutics operates within a clinical development framework focused on its pipeline of immunotherapeutic products. Revenue is primarily generated through partnerships and collaborations with research institutions, alongside licensing agreements for its technologies. The firm's flagship products, including ITI-1001, are positioned within clinical trials that may lead to future revenue streams upon successful commercialization and regulatory approvals. The company is focused on launching new products and may seek to enter new geographical markets, specifically targeting regions in Europe and Asia by 2023.
Who invested in Immunomic Therapeutics
4 investors across 2 rounds
See all investors in Immunomic Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Immunomic Therapeutics
Who invested in Immunomic Therapeutics?
Immunomic Therapeutics has 4 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Immunomic Therapeutics raised?
Immunomic Therapeutics has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Immunomic Therapeutics last raise money?
Immunomic Therapeutics's most recent round on record is a Series A, in Mar 2010.
What does Immunomic Therapeutics do?
Immunomic Therapeutics is a pharmaceuticals company.
Where is Immunomic Therapeutics headquartered?
Immunomic Therapeutics is headquartered in Rockville, US.
Which VCs invest in companies like Immunomic Therapeutics?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back pharmaceuticals companies at Immunomic Therapeutics's stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Series A
Raising like Immunomic Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.